Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis.
Anirban BasuAaron N WinnKate M JohnsonBoshen JiaoEmily Beth DevineJane Silva HankinsStaci D ArnoldM A BenderScott D RamseyPublished in: Annals of internal medicine (2024)
National Heart, Lung, and Blood Institute.